Paul T. Quinlan, General Counsel at CymaBay Therapeutics, Inc. (CBAY), sold 29,000 shares at $16.87 ($489K) on 2023-09-15, disclosed to the SEC on 2023-09-19.
Open-market sale of $489k CBAY by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.87 | 5,000 | $84K | 17.2% |
| 2 | $16.87 | 24,000 | $405K | 82.8% |
| Total | $16.87 avg | 29,000 | $489K | 100% |
| Filing → |
| ORKA | SELL | 2026-08-14 | $5.6M | — | Filing → |
| ORKA | SELL | 2026-06-15 | $51K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $30K | — | Filing → |